molybdenum has been researched along with Medulloblastoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashikaga, T; Bond, J; Brard, L; Illenye, S; Kim, K; Koto, KS; Lescault, P; Saulnier Sholler, GL; Singh, RK; Slavik, MA | 1 |
1 other study(ies) available for molybdenum and Medulloblastoma
| Article | Year |
|---|---|
Antitumor activity of nifurtimox is enhanced with tetrathiomolybdate in medulloblastoma.
Topics: Apoptosis; Cell Line, Tumor; Cerebellar Neoplasms; DNA Damage; Drug Synergism; Humans; Medulloblastoma; Molybdenum; NF-E2-Related Factor 2; Nifurtimox; Reactive Oxygen Species | 2011 |